PMC:7534795 / 21307-21402 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T153","span":{"begin":30,"end":41},"obj":"Chemical"}],"attributes":[{"id":"A153","pred":"chebi_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":"85.7% received single dose of tocilizumab, 14.3% required second dose within 12 h of first dose"}

{"project":"LitCovid-PubTator","denotations":[{"id":"668","span":{"begin":30,"end":41},"obj":"Chemical"}],"attributes":[{"id":"A668","pred":"tao:has_database_id","subj":"668","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"85.7% received single dose of tocilizumab, 14.3% required second dose within 12 h of first dose"}